Rhinoscleroma as a Cause of Airway Obstruction
Seth N. Goldberg, M.D., and Rinaldo F. Canalis, M.D.
Two cases ofrhinoscleroma presenting with airway obstruction are described to emphasize the continuing incidence of this disease and the need for proper techniques of diagnosis and management.
Rhinoscleroma is a chronic progressive infectious disease of the respiratory tract that can produce serious disability and, if untreated, even death. It is endemic in Eastern Europe, the Middle East, and parts of Latin America. In the United States, on the other hand, only some 200 cases have been reported.
In recent years this country has experienced a large influx of persons from these endemic areas, resulting in an increased incidence of rhinoscleroma. In this article we present two unusual cases manifesting severe airway obstruction. The clinical features, diagnostic aids, and the need for early and prolonged antibiotic treatment are discussed. 6 CASE REPORTS Case 1. ].M., a 24-year-old Mexican, presented with a five-year history of persistent bilateral nasal obstruction, mild intermittent epistaxis, and purulent nasal discharge. In addition, he reported a one-month history of gradually progressive dyspnea and mild hoarseness. Physical examination revealed the patient to have moderately severe inspiratory and expiratory stridor. The nasal vestibules were narrowed, and the nasal cavities were filled with exuberant friable granulation tissue and crusts. Small mucosal nodules were present on the posterior oropharyngeal wall, which was also markedly narrowed by crusts. Similar crusting was seen in the endolarynx. Chest x-ray and admission laboratory studies produced normal findings. Sinus radiographs and tomography revealed opacified maxillary antra, with possible bony destruction of the left lateral nasal wall. Tracheostomy was placed to protect the patient's airway, and then direct laryngoscopy was performed. Biopsies of granulation tissue from the nose, oropharynx, and subglottic region all showed intracellular gram-negative rods in "foamy cells" compatible with rhinoscleroma ( Figure 1 ). Cultures of the biopsies grew Klebsiella rhinoscleromatis sensitive to several antibiotics, including tetracycline. A daily regimen of 2 gm. of tetracycline was prescribed, and, after one month of treatment, all granulation tissue disappeared. Intranasal and subglottic inflammation and crusting persisted, but subsequent cultures and biopsies failed to demonstrate the organisms. Nine months after the institution of therapy the patient developed a rash, but this. disappeared following discontinuation of tetracycline. The nasal symptoms recurred four weeks later, and the patient was given 2 gm. of cephalexin daily for six months; after that, the dosage was reduced to 1 gm. daily, given for another six months. The patient has now been off therapy for four years without evidence of relapse. Nasopharyngeal scarring, resulting in serous otitis media, and anterior glottic webbing persist as sequelae.
Ear, Nose, & Throat Journal 146 Case 2. R.F., a 20-year-old man from Guatemala who has lived in Los Angeles for 11 years, presented with a four-month history of hoarseness and increasing dyspnea on exertion. He had also noted some purulent rhinorrhea during the same period.
Physical examination showed an anxious man with audible stridor at rest. Examination of the nose revealed normal-appearing mucosa and purulent discharge coming from beneath both middle turbinates. The sinuses were not tender. Purulent discharge with normal underlying mucosa was noted on indirect examination of the nasopharynx. Indirect laryngoscopy revealed paramedian fixation of the left true vocal cord. The right true cord abducted weakly, and both cords were slightly erythematous and thickened. A subglottic mass was visible on the anterior tracheal wall. Findings on admission laboratory studies and chest x-rays were within normal limits. Soft-tissue neck x-rays ( Figure 2 
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demonstrated circumferential narrowing of the glottic and subglottic airway to approximately half of normal size. The stenosis extended approximately 4 ern. beneath the true cords.
A low tracheostomy was performed. Direct laryngoscopy revealed granulation tissue narrowing the tracheal lumen concentrically. Biopsies revealed characteristic foamy macrophages. Cultures of this tissue and nasal discharge grew K. rhinoscleromatis sensitive to gentamicin, tetracycline, and kanamycin. Tetracycline (2 gm. per day) was begun. One month later the subglottic airway had a normal appearance, and the tracheostomy was allowed to close. The patient has had no recurrence of his disease seven months into his course of therapy. quent symptoms include upper-lip swelling, sore throat, and epiphora. The most common physical finding is granular erythematous swelling of the mucous membranes of the nose and nasopharynx, with overlying crusting. The granulations may be so prolific as to totally obstruct the nasal airway. In advanced cases of nasal disease, tissue destruction and scarring may distort the anatomy to the extent of disfigurement. The paranasal sinuses, larynx, and trachea may also be affected. Airway obstruction, hemorrhage, or intracranial extension may result in death.
Transmission of rhinoscleroma occurs by physical contact with persons in the active stages of the disease. The disease progresses through three overlapping stages. The rhinitic stage is characterized by mucopurulent nasal discharge; biopsy usually reveals nonspecific inflammation. The florid stage is a granulomatous reaction of the mucosa, while the fibrotic stage represents the resolution of the disease with cicatrix formation and subsequent anatomic deformity. Acute laryngeal and tracheal disease may produce obstruction serious enough to require tracheostomy. In the series of 11 cases of rhinoscleroma in the larynx, trachea, and bronchi reported by Holinger et aI., 1 severe obstruction requiring tracheostomy occurred in nine patients (82 percent). During the past six years, one of us (R.F.C.) has had experience with 16 cases of previously untreated rhinoscleroma presenting in the florid stage of the disease. Of these, biopsy-proved laryngeal impairment was present in eight patients; only two (12.5 percent) had significant upper-respiratory obstruction. With or without therapy, healing laryngeal disease may result in scarring, which can produce a characteristic anterior glottic webbing. Subglottic scarring is less common but may require dilatation. Pathology and laboratory diagnosis. The presumed etiologic agent, K. rhinoscleromatis, is a short gram-negative rod best cultured from a biopsy of affected tissue. Biopsies during the florid stage of the disease reveal a profuse subepithelial inflammatory infiltrate Ear, Nose, & Throat Journal 148 consisnng primarily of plasma cells, fibroblasts, and large vacuolated cells containing the microorganisms. The last-mentioned elements are known as Mikulicz cells and are pathognomonic of the disease. The origin of the Mikulicz cell is unknown, although current evidence suggests that it is derived from histiocytes.? Periodic acid-Schiff reagent facilitates demonstration of the intracellular organisms. Treatment. A number of antibiotics have been used to treat rhinoscleroma, including streptomycin ,!" tetracycline.v' chloroamphenicol;' cephalexin," and kanamycin." Sulfonamides and penicillin, however, are ineffective. Although Shaw and Martin" have recommended surgical excision of isolated lesions, our experience is that antibiotic therapy has been as effective as surgery in the management of these cases." Antibiotic therapy with 2 gm. of tetracycline per day, given in divided doses, is the choice for active disease. We prefer this regimen because it is highly effective and relatively inexpensive and carries fewer toxic side effects.
There is now convincing laboratory evidence not only that the Mikulicz cell is unable to destroy K. rhinoscleromatis but also that it effectively protects the bacterium from circulating antibiotics." It is only when these cells break down, liberating the phagocytized bacil- 
PATIENT PACKAGE INSERTS: A CONCEPT WHOSE TIME HAS COME?
The consumers right to know is an irreversible and desirable trend of the Seventies. It extends, and properly, toa patients right to know mare about his or her prescription medications. One way, gaining favor. is through patient package inserts. Wisely-prepared and properly distributed when medically indicated, they could markedly improve patient knowledge and drug therapylaudable goals by anyones standards.
The PMAendorses these goals and will work with government, the health professions and consumers to achieve them.
The Advantag=es _
The concept holds promise of benefits: better patient understanding of the product prescribed, better adherence to the treatment plan, and more awareness of possible side reactions. Every doctor has had patients who fail to finish antibiotic regimens because they feel better. Some patients assume that if one tranquilizer or analgesic is good, two may be twice as good. Still others fail to report dizziness whileon antihypertensive therapy -and so on.
Problems like these might arise less often if the patient received written information in addition to verbal instructions. Some studies suggest that patients are more receptive to such materials, and they more often understand the verbal instructions and followthem, when inserts are used.
The Disadvantage.:;..:;s_ _
There are also some potential problems. Obviously, the inserts must be clearly phrased, without extraneous or complexdetail. How much information is enough? How can it be kept current? Should all patients receive the same information? Should inserts be included with all drugs? Should only potential problems be listed or are patients better off with a "fair balance" presentation that describes usefulness as well as drawbacks?
These and similar questions require answers, since model inserts have yet to be properly developed and tested. Despite the need for these studies, the FDA is proceeding prematurely with inserts on selected products. We think the Congress is the only place where the matter can be given the proper legal status and direction, particularly since it represents a conceptual change in the legal, medical and social framework of the nation's prescription drug information system.
The Solution
The PMA believes that carefullydevised pilot studies of various kinds of inserts are needed. They should be developed and implemented with full participation by doctors, pharmacists. consumers, communications experts and the drug industry. Such studies will provide reliable pathways to follow, so that inserts will be useful aids to medical practice.
And particularly we think that you should be closely involved in this debate and in these studies and decisions. Otherwise, people with less experience and qualifications may control the purposes, content and use of a tool with considerable promise for improved patient care. It could make a difference in your practice tomorrow, and more importantly, in the health of your patients. 
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In counting words, please note the following: Each abbreviation is considered one word. li, that antibiotic therapy is effective. Since the duration of this cycle is unknown but appears to be prolonged, relapses are to be expected when only short-term antibiotic therapy is used. Empirically, treatment must be continued for at least 12 months to prevent recurrence of the disease.
CONCLUSIONS
Both of our cases illustrate dramatic presentations of what has heretofore been a rare disease in this country. A differential diagnosis of rhinoscleroma includes clinically similar processes, such as acute and chronic bacterial rhinosinusitis, Wegener's granulomatosis, malignant reticulosis, sarcoidosis, tuberculosis, leprosy, and carcinoma. A history of living in endemic areas should alert the clinician to a consideration of rhinoscleroma in the differential diagnosis. Biopsy of the affected tissue and its culture and pathologic examination will be diagnostic. Laryngeal obstruction is uncommon, but it must also be considered in the differential diagnosis for patients requiring an emergency airway.
It should be remembered that the stage of resolution of the disease includes cicatrix formation. If the later complications of nasal deformity and obstruction, as well as glottic and subglottic stenosis, are to be avoided, careful long-term follow-up and appropriate surgical treatment are necessary. 0 BIBLIOGRAPHY
